At a Glance
Venrock stands as one of Silicon Valley's most enduring venture capital institutions, tracing its origins to the Rockefeller family's 1969 decision to formalize their technology investments. The firm emerged from Rockefeller Family & Associates, establishing itself as an early pioneer in venture capital when the industry was still nascent. Over five decades, Venrock has deployed capital across multiple technology cycles, building a reputation for backing transformative companies in enterprise software, healthcare technology, and biotechnology. The firm's most celebrated investment remains Apple Computer, where Venrock partner Arthur Rock served as chairman and helped guide the company through its early public years. This investment alone generated returns that cemented Venrock's position among venture capital's elite. Beyond Apple, Venrock's portfolio includes significant healthcare investments such as Illumina, the genomic sequencing giant that went public in 2000, and more recent enterprise successes like Nicira, which VMware acquired for $1.26 billion in 2012. The firm has also backed Dollar Shave Club, sold to Unilever for $1 billion in 2016. Venrock's healthcare practice has been particularly distinguished, with investments spanning from traditional biotech companies developing novel therapeutics to digital health platforms transforming care delivery. The firm's enterprise practice focuses on infrastructure software, cybersecurity, and artificial intelligence applications. With approximately $3 billion in assets under management, Venrock typically invests $1-15 million in seed and Series A rounds, though the firm occasionally participates in later-stage rounds for portfolio companies. The firm's investment committee approach emphasizes consensus building, with partners bringing deep domain expertise to evaluate opportunities. Venrock's longevity has provided unique advantages, including extensive networks across multiple generations of entrepreneurs and the ability to maintain patient capital strategies. The firm's Palo Alto headquarters positions it at the center of Silicon Valley deal flow, while maintaining a disciplined approach to market cycles that has enabled consistent returns across its fund history.
“Backs bold founders in technology and healthcare who are building companies that will define the future of their industries.”
Venrock's partnership combines healthcare and technology veterans with proven track records in company building and sector expertise. The firm's healthcare practice is led by partners with both investing and operational experience in biotechnology and digital health. On the enterprise side, partners bring backgrounds from successful technology companies and prior venture investing roles. The partnership structure emphasizes collaborative decision-making, with partners actively involved in board roles and strategic guidance for portfolio companies. Venrock's team stability has been a distinguishing characteristic, with several partners maintaining decade-plus tenures at the firm, providing continuity in relationships with entrepreneurs and limited partners.
Venrock has raised approximately fifteen funds since its 1969 founding, with recent funds typically ranging from $400-500 million in size. The firm's fund strategy has evolved from generalist technology investing to focused practices in enterprise software and healthcare. Early funds benefited significantly from Apple and other foundational technology investments, while more recent funds have emphasized the firm's sector expertise in healthcare innovation and enterprise infrastructure. The firm maintains a disciplined approach to fund sizing relative to market opportunities.
Venrock primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
Venrock is headquartered in Palo Alto, CA. Many of their portfolio companies are also based in this region, though they invest across geographies.
Venrock focuses on investments in Enterprise, Digital Health, Biotech, AI. Their portfolio reflects deep expertise and networks within these sectors.
Venrock's typical investment check size ranges from $500K to $20M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Venrock manages approximately $3B in assets under management (AUM) across their funds.
